Rep. John R. Moolenaar

Maddy summaryThis bill, titled "Pet and Livestock Protection Act," is misleading; it actually focuses on gray wolf management. It requires the Secretary of the Interior to reissue a 2020 rule removing gray wolves from the endangered species list within 60 days of enactment. The bill also prohibits courts from reviewing this reissuance. This directly affects gray wolf populations and management policies in states where wolves are present, shifting regulatory control away from federal endangered species protections.

Essential Caregivers Act of 2025   This bill prohibits certain health care facilities from limiting the access of essential caregivers to residents of those facilities, including during designated emergency periods.   Specifically, the bill generally prohibits Medicare skilled nursing facilities, Medicaid nursing facilities, Medicaid intermediate care facilities, and associated inpatient rehabilitation facilities from restricting the access of essential caregivers to residents of the facilities, including during emergency periods in which visitation rights are otherwise restricted. During emergency periods, facilities may restrict access for an initial period of up to seven days and for one additional maximum seven-day period (if the additional period is approved by the state health department). Facilities may restrict access for a total of 7 days (or 14 days with the approval of the state health department) during an emergency period. Essential caregivers must agree to comply with any safety protocols set by the facility, which may be no more stringent for caregivers compared to those for staff. Caregivers who fail to comply with these requirements may be denied access, subject to an appeals process.

Maddy summaryHR 6707, the CFIUSMCA Act, directs the U.S. Trade Representative to advocate during USMCA joint reviews for Mexico and Canada to adopt foreign investment review frameworks similar to the U.S. Committee on Foreign Investment (CFIUS) process. It aims to create a coordination mechanism among the U.S., Mexico, and Canada for sharing information and managing national security risks in strategically important sectors like semiconductors, artificial intelligence, critical infrastructure, and cybersecurity. The bill requires U.S. agencies to provide technical assistance to Mexico and Canada to help them establish these aligned frameworks and mandates regular communication to address shared threats from foreign investments. This legislation directly affects U.S. trade and security officials, as well as the foreign investment review processes of Mexico and Canada under the USMCA agreement.

Miracle on Ice Congressional Gold Medal Act This act provides for the award of Congressional Gold Medals to the members of the 1980 U.S. Olympic men's ice hockey team in recognition of the team's achievement at the 1980 Winter Olympic Games.

Maddy summaryHR 6576, the SAFE LiDAR Act, prohibits U.S. businesses and critical infrastructure operators (like utilities, transportation systems, and government entities) from using LiDAR technology developed or controlled by countries designated as "foreign adversaries" (China, Russia, Iran, North Korea) after specific deadlines. It bans new transactions involving such technology starting three years after enactment and requires existing systems to transition within five years, with limited waivers available for national security or critical infrastructure needs. Key exemptions include research, testing, legacy systems in use before enactment, and products exported outside the U.S. The bill establishes a process for waivers, a national security task force, and annual reporting to Congress on enforcement actions and emerging threats.

Maddy summaryHR 6487, the SECURE STEM Act, prohibits U.S. visa issuance and admission for nationals of China, Russia, Iran, North Korea, and Cuba seeking certain STEM-related visas (including H-1B, J-1, and student visas). It also bans these individuals from working at federal national research laboratories. The law allows limited national interest waivers for specific cases, requiring joint approval from the State and Homeland Security Secretaries. It mandates biannual reports to Congress detailing waiver approvals, justifications, and recipient information. The bill directly affects foreign nationals from the specified countries pursuing STEM education or research roles in the U.S. federal labs.

Maddy summaryHRES 930 is a symbolic resolution designating December 8, 2025, as "Jimmy Lai Day" to honor Jimmy Lai's advocacy for free press, religious freedom, and democracy in Hong Kong. It calls on the People's Republic of China and Hong Kong authorities to release Jimmy Lai and other Hong Kong prodemocracy advocates detained under Hong Kong's National Security Law. The resolution does not create new laws or policies but expresses congressional support for Lai's work and condemns the imprisonment of those advocating for Hong Kong's freedoms. It directly affects U.S. diplomatic messaging toward China, not Hong Kong's legal system or residents.

Maddy summaryHR 6466, the Forced Abortion Prevention and Accountability Act, prohibits non-consensual administration of abortion drugs (like mifepristone or misoprostol) to pregnant women without their informed consent. It criminalizes this act with penalties up to 25 years in prison and allows victims to sue for triple damages, psychological/physical injury compensation, and attorney fees. The bill directly affects pregnant women who might face coerced procedures and medical providers or others who administer such drugs without consent. Key provisions include criminal penalties for the act itself, enhanced penalties for serious injury or death, and a civil remedy framework for victims seeking compensation.

Maddy summaryThis bill establishes a new interagency Task Force to dismantle foreign scam operations targeting Americans, particularly through "pig butchering" scams in Southeast Asia. The Task Force, chaired by the Secretary of State, will coordinate efforts across multiple agencies to shut down scam centers, impose sanctions on perpetrators, and support victims of trafficking. It requires a detailed strategy within 180 days and annual reports to Congress on progress, including sanctions imposed and funds recovered. The bill authorizes $30 million for these efforts in fiscal years 2026-2027, focusing on countries like Cambodia, Laos, and Burma where scam centers operate with forced labor.

Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.  Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.  The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)